3rd Annual Atlanta Precision Oncology Symposium
Video Player is loading.
10 seconds
Playback speed
Targeted Therapies for Advanced Urothelial Cancer: Erdafitinib for Patients With FGFR3 Alterations, 3L Enfortumab Vedotin and IMMU-132
Comments 0
Login to view comments.
Click here to Login
